Skip to main content
Fig. 4 | Journal of Translational Medicine

Fig. 4

From: Demethylation at enhancer upregulates MCM2 and NUP37 expression predicting poor survival in hepatocellular carcinoma patients

Fig. 4

MCM2 and NUP37 overexpression correlated with worse survival in HCC patients. Aā€“B Box plots showing mRNA of MCM2 or NUP37 significantly correlates with the clinical stage of HCC. * pā€‰<ā€‰0.05, *** pā€‰<ā€‰0.001, based on Wilcoxon test. Cā€“D Kaplanā€“Meier survival analysis was performed to assess the impact of MCM2 and NUP37 on survival of HCC patients from 3 independent cohorts. p is based on log-rank test. TCGA cohort (nā€‰=ā€‰370); NODE cohort (nā€‰=ā€‰150), and ZHE YI Cohort (nā€‰=ā€‰300). Eā€“F Forest plots showing Cox univariate and multivariate survival analyses results in ZHE YI Cohort

Back to article page